DISCLAIMER
The information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.compose your message
message sent
email sent successfully
rareLife solutions 606 Post Road East #397 Westport, CT 06880 |
||
You are receiving this because you have an account on www.oneAMYLOIDOSISvoice.com | ||
To unsubscribe from these emails, click here |
Trusted Resources: Community Center
Online support, community stories, financial assistance
hATTR Compass Genetic Testing and Counseling Program
Akcea Therapeutics and Ambry Genetics are partnering to offer anonymous, no-cost genetic testing and confidential genetic counseling to patients suspected of having or clinically diagnosed with hATTR amyloidosis through the hATTR Compass Program.
hATTR Compass is Designed to:
• Help accelerate or confirm the diagnosis of hATTR amyloidosis.
• Provide support and resources to patients, caregivers and healthcare professionals throughout the genetic testing process.
• Empower patients and their healthcare professionals to make the most informed decisions about their health care.
The hATTR Compass Program is available for patients in the U.S. and Canada who are 18 years and older and have a family history of hATTR amyloidosis. If there is no family history, the patient must have at least two clinical symptoms or manifestations related to hATTR amyloidosis.
Share
myBinder
Related Content
-
news & meetingsWith CRISPR Gene Editing, Unique Treatments Begin to Take off for Rare DiseasesIn February last year, Doherty — now a...
-
news & meetingsWhy There’s New Hope if You Have Cardiac AmyloidosisAmyloidosis is a disorder in which c...
-
news & meetingsUltromics granted FDA Breakthrough Device Designation for AI-enhanced Cardiac Amyloidosis detectionOxford, UK, April 26th, 2023 — Ultrom...
-
educationCerebral Amyloid Angiopathy Mimicking Central Nervous System Metastases: A Case ReportBackground: This case describes an unus...
-
educationAmyloidosis Diagnosis & TreatmentAmyloidosis is often overlooked because ...
-
news & meetingsEplontersen halted ATTRv-PN disease progression and improved neuropathy impairment and quality of life in Phase 3 st...CARLSBAD, Calif., April 24, 2023 /PRNe...
-
videos & visualsNew Treatments for Cardiac Amyloidosishttps://www.youtube.com/watch?v=QNTYRFIA...
send a message
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.